Clonidine Hydrochloride Injection
If you find any inaccurate information, please let us know by providing your feedback here

Tóm tắt nội dung
This article is compiled based on the United States Pharmacopeia (USP) – 2025 Edition
Issued and maintained by the United States Pharmacopeial Convention (USP)
1 DEFINITION
Clonidine Hydrochloride Injection is a sterile solution of Clonidine Hydrochloride in Water for Injection. It contains NLT 90.0% and NMT 110.0% of the labeled amount of clonidine hydrochloride (C9H9Cl2N3 · HCl).
2 IDENTIFICATION
A. The retention time of the major peak of the Sample solution corresponds to that of the Standard solution, as obtained in the Assay.
B. SPECTROSCOPIC IDENTIFICATION TESTS (197), Ultraviolet-Visible Spectroscopy: 1970
Diluent: 9 g/L of sodium chloride in water
Standard solution: 0.1 mg/mL of USP Clonidine Hydrochloride RS in Diluent. Sonicate to dissolve, if needed.
Sample solution: Nominally 0.1 mg/mL of clonidine hydrochloride from Injection. Dilute with Diluent, if needed.
Acceptance criteria: The UV spectrum of the Sample solution exhibits maxima and minima at the same wavelengths as that of the Standard solution.
3 ASSAY
3.1 PROCEDURE
Solution A: Dilute 2.0 mL of perchloric acid (70%), in 4000 mL of water.
Solution B: Acetonitrile and methanol (95:5)
Mobile phase: Solution A and Solution B (85:15)
Diluent: 9 g/L of sodium chloride in water
Standard solution: 0.01 mg/mL of USP Clonidine Hydrochloride RS in Diluent. Sonicate to dissolve, if needed.
Sample solution: Nominally 0.01 mg/mL of clonidine hydrochloride from the Injection, diluted with Diluent
3.1.1 Chromatographic system
(See Chromatography (621), System Suitability.)
Mode: LC
Detector: UV 210 nm
Column: 3.0-mm x 15-cm; 5-µm packing L56
Flow rate: 1.2 mL/min
Injection volume: 25 µL
Run time: NLT 2 times the retention time of clonidine
3.1.2 System suitability
Sample: Standard solution
3.1.3 Suitability requirements
Tailing factor: NMT 1.5
Relative standard deviation: NMT 1.0%
3.1.4 Analysis
Samples: Standard solution and Sample solution
Calculate the percentage of the labeled amount of clonidine hydrochloride (C9H9Cl2N3 · HCl) in the portion of Injection taken:
Result = (rU/rS) x (CS/CU) × 100
rU = peak response of clonidine from the Sample solution U
rS = peak response of clonidine from the Standard solution 5
CS = concentration of USP Clonidine Hydrochloride RS in the Standard solution (mg/mL)
CU = nominal concentration of clonidine hydrochloride in the Sample solution (mg/mL)
Acceptance criteria: 90.0%-110.0%
4 IMPURITIES
4.1 ORGANIC IMPURITIES
Solution A, Solution B, and Diluent: Prepare as directed in the Assay.
Mobile phase: See Table 1.
Table 1
| Time (min) | Solution A (%) | Solution B (%) |
| 0 | 97 | 3 |
| 35 | 50 | 50 |
| 50 | 50 | 50 |
| 51 | 97 | 3 |
| 60 | 97 | 3 |
Sensitivity solution: 0.05 µg/mL of USP Clonidine Hydrochloride RS in Diluent
Standard solution: 0.5 µg/mL of USP Clonidine Hydrochloride RS in Diluent. Sonicate to dissolve, if needed.
Sample solution: Nominally 100 µg/mL of clonidine hydrochloride from the Injection. Dilute with Diluent, if needed.
Chromatographic system: Proceed as directed in the Assay, except for the Flow rate and the Run time.
Flow rate: 1 mL/min
Run time: 60 min
4.1.1 System suitability
Samples: Sensitivity solution and Standard solution
4.1.2 Suitability requirements
Relative standard deviation: NMT 10.0%, Standard solution
Signal-to-noise ratio: NLT 10, Sensitivity solution
4.1.3 Analysis
Samples: Standard solution and Sample solution
Calculate the percentage of any unspecified impurity in the portion of Injection taken:
Result = (rU/rS) x (CS/CU) × 100
rU = peak response of any unspecified impurity from the Sample solution
rS = peak response of clonidine from the Standard solution S
CS = concentration of USP Clonidine Hydrochloride RS in the Standard solution (µg/mL)
CU = nominal concentration of clonidine hydrochloride in the Sample solution (µg/mL)
Acceptance criteria: See Table 2.
Table 2
| Name | Relative Retention Time | Acceptance Criteria, NMT (%) |
| Clonidine | 1.0 | — |
| N-(2,6-Dichlorophenyl)formamidea | 1.4 | — |
| 2,6-Dichloroanilinea | 3.0 | — |
| 2,6-Dichloroacetanilidea | 3.5 | — |
| (2,6-Dichlorophenyl)carbonimidic dichloridea | 5.1 | — |
| Any unspecified impurity | — | 0.30 |
| Total impurities | — | 0.75 |
a Process impurity for peak identification only; not to be reported or included in the total impurities.
5 SPECIFIC TESTS
PH (791): 5.0-7.0
PARTICULATE MATTER IN INJECTIONS (788): Meets the requirements for small-volume injections
Change to read:
OSMOLALITY AND OSMOLARITY (785)
Osmolality: ▲(Official 1-Aug-2022) 270-330 mOsmol/kg
STERILITY TESTS (71): Meets the requirements
BACTERIAL ENDOTOXINS TEST (85): Meets the requirements
6 ADDITIONAL REQUIREMENTS
PACKAGING AND STORAGE: Preserve in well-closed Type 1 glass vials. Store at controlled room temperature.
USP REFERENCE STANDARDS (11)
USP Clonidine Hydrochloride RS

